Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 61

BillFederalSenateIn Committee
A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.
About This Bill
Committee
Latest Action · January 9, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
January 9, 2019
Sponsor
Sen. Charles GrassleyR
Cosponsors (12)
10D 1R
View PDF ↗

Summary

Highlight any text to annotate
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.